Kutatási jelek – Signal Engine

• Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study — Hepatocellular carcinoma
• Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country survey — Multiple myeloma
• Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma. — Multiple myeloma
• Research on predicting the progression of multiple myeloma treated with bortezomib based on multimodal ensemble learning — Multiple myeloma
• Evaluation of Organ Stiffness and Cardiac Function in Myelofibrosis Patients Treated with Ruxolitinib — Myelofibrosis
• Preliminary safety and efficacy of navitoclax plus ruxolitinib in JAK‑inhibitor‑naïve patients with myelofibrosis: REFINE phase 2 study — Myelofibrosis
• Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials — Myelofibrosis
• From Immune Dysfunction to Clinical Risk: Infections in Myelofibrosis — Myelofibrosis
• Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era — Myelofibrosis
• Population Pharmacokinetics and Exposure‑Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis — Myelofibrosis
• The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel — Myelofibrosis
• Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST). — Gastrointestinal stromal tumor
• Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors — Gastrointestinal stromal tumor
• Single-agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT‑MF0035 Study — Myelofibrosis
• Chromatin Remodeling Subunit ARID1A Negatively Regulates the Malignant Progression of Gastrointestinal Stromal Tumors by Targeting the MEMO1 Promoter — Gastrointestinal stromal tumor
• Clinical Features and Factors Contributing to Preoperative Misdiagnosis of Gastric Gastrointestinal Stromal Tumors: A Retrospective Analysis of 27 Cases — Gastrointestinal stromal tumor
• Role of Radiotherapy in the Multidisciplinary Treatment of Lacrimal Gland Adenoid Cystic Carcinoma — Adenoid cystic carcinoma
• Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study. — Adenoid cystic carcinoma
• PRAME promotes invasion and metastasis of salivary adenoid cystic carcinoma by regulating RARα stability via the cullin2 ubiquitin‑proteasome system — Hepatocellular carcinoma
• Clinical Characteristics and Survival in Adenoid Cystic Carcinoma of Salivary and Nonsalivary Sites — Breast cancer